-
公开(公告)号:US20120035196A1
公开(公告)日:2012-02-09
申请号:US13265781
申请日:2010-04-21
申请人: Kenji Negoro , Kei Ohnuki , Yasuhiro Yonetoku , Kazuyuki Kuramoto , Yasuharu Urano , Hideyuki Watanabe
发明人: Kenji Negoro , Kei Ohnuki , Yasuhiro Yonetoku , Kazuyuki Kuramoto , Yasuharu Urano , Hideyuki Watanabe
IPC分类号: A61K31/505 , C07C63/36 , A61K31/216 , A61K31/192 , C07D239/34 , C07D305/06 , A61K31/337 , C07D207/46 , A61K31/4015 , C07D309/10 , A61K31/351 , C07D317/18 , A61K31/341 , A61P3/10 , C07C69/616
CPC分类号: C07D207/06 , A61K31/40 , A61K31/4015 , C07C49/417 , C07C59/68 , C07C59/72 , C07C69/732 , C07C69/734 , C07C229/42 , C07C233/18 , C07C235/20 , C07C255/37 , C07C271/30 , C07C311/04 , C07C2603/18 , C07C2603/94 , C07D207/27 , C07D239/34 , C07D305/06 , C07D307/94 , C07D309/06 , C07D309/10 , C07D317/22 , C07D319/06 , C07D405/12
摘要: [Problem]The present invention has an object to provide a compound having a GPR40 agonistic activity, which is useful as a pharmaceutical composition, an insulin secretion promoter, or an agent for preventing/treating diabetes.[Means for Solution]The present inventors have extensively studied a compound having a GPR40 agonistic activity, and as a result, they have found that the compound (I) of the present invention or a pharmaceutically acceptable salt thereof, in which a carboxylic acid is bonded to a bicyclic or tricyclic moiety through methylene, and further, a benzene ring substituted with a monocyclic 6-membered aromatic ring is bonded to a bicyclic or tricyclic moiety through —O-methylene or —NH-methylene, has an excellent GPR40 agonistic activity. They have also found that the compound has an excellent insulin secretion promoting action and strongly inhibits increase in the blood glucose after glucose loading, thereby completing the present invention.
摘要翻译: 本发明的目的是提供具有GPR40激动活性的化合物,其可用作药物组合物,胰岛素分泌促进剂或糖尿病预防/治疗剂。 [解决方案]本发明人广泛研究了具有GPR40激动活性的化合物,结果发现本发明的化合物(I)或其药学上可接受的盐,其中羧酸为 通过亚甲基键合到双环或三环部分,此外,被单环6元芳环取代的苯环通过-O-亚甲基或-NH-亚甲基与双环或三环部分连接,具有优异的GPR40激动活性 。 他们还发现该化合物具有优异的胰岛素分泌促进作用,并且强烈地抑制葡萄糖负荷后血糖的增加,从而完成本发明。
-
公开(公告)号:US07557127B2
公开(公告)日:2009-07-07
申请号:US12264363
申请日:2008-11-04
申请人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
发明人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
IPC分类号: C07D401/12 , C07D403/12 , A61K31/497 , A61K31/506 , A61K31/501
CPC分类号: C07D213/74 , C07C259/06 , C07D207/14 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
摘要: Compounds having the formula (I): wherein R1 is hydrogen, lower alkyl, lower alkenyl, lower or higher alkynyl, cyclo(lower)alkyl, cyclo(higher)alkyl, cyclo(lower)alkyl(lower)alkyl, cyclo(higher)alkyl(lower)alkyl, cyclo(lower)alkenyl(lower)alkyl, aryl-fused cyclo(lower)alkyl, lower alkoxy, acyl, aryl, ar(lower)alkoxy, ar(lower)alkyl, heteroar(lower)alkyl, amino, heteroaryl, heterocyclyl or heterocyclyl(lower)alkyl, which may be substituted with one or more suitable substituent(s), R2 is hydrogen or lower alkyl, X is pyrrolidinylene or piperidinylene, Y is pyridylene, which may be substituted with one or more suitable substituent(s), Z is lower alkenylene, which may be substituted with lower alkyl or halogen, and salts thereof are useful as a histone deacetylase inhibitors.
摘要翻译: 具有式(I)的化合物:其中R1是氢,低级烷基,低级烯基,低级或高级炔基,环(低级)烷基,环(高级)烷基,环(低级)烷基(低级)烷基, 烷基,低级烷基,低级烷基,低级烷基,低级烷基,低级烷基,低级烷基,低级烷基, 氨基,杂芳基,杂环基或杂环基(低级)烷基,其可以被一个或多个合适的取代基取代,R 2是氢或低级烷基,X是吡咯烷基或哌啶子基,Y是亚吡啶基,其可以被一个或多个 更合适的取代基,Z是低级亚烯基,其可以被低级烷基或卤素取代,其盐可用作组蛋白脱乙酰酶抑制剂。
-
公开(公告)号:US20100256113A1
公开(公告)日:2010-10-07
申请号:US12680301
申请日:2008-09-25
申请人: Kenichi Onda , Kenichiro Imamura , Fumie Sato , Hiroyuki Moritomo , Yasuharu Urano , Yuki Sawada , Naoki Ishibashi , Keita Nakanishi , Kazuhiro Yokoyama , Shigetada Furukawa , Kazuhiro Momose
发明人: Kenichi Onda , Kenichiro Imamura , Fumie Sato , Hiroyuki Moritomo , Yasuharu Urano , Yuki Sawada , Naoki Ishibashi , Keita Nakanishi , Kazuhiro Yokoyama , Shigetada Furukawa , Kazuhiro Momose
IPC分类号: A61K31/4709 , C07D215/233 , C07D405/12 , C07D401/12 , C07D413/12 , A61K31/47 , A61K31/506 , A61K31/5377 , A61K31/496 , A61K31/4725 , A61K31/55 , A61K31/553
CPC分类号: C07D401/12 , C07D215/233 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/107
摘要: As a result of extensive studies on NAD(P)H oxidase inhibitors, the present inventors found that a quinolone derivative having, at the 2-position, an alkyl group substituted with a heteroatom or the like has an excellent NAD(P)H oxidase inhibitory activity, and accomplished the present invention. The compound of the present invention has a reactive oxygen species production inhibitory activity based on the NAD(P)H oxidase inhibitory activity, and therefore can be used as an agent for preventing and/or treating diabetes, impaired glucose tolerance, hyperlipidemia, fatty liver, diabetic complications and the like.
摘要翻译: 作为对NAD(P)H氧化酶抑制剂的广泛研究的结果,本发明人发现,在2位具有被杂原子等取代的烷基的喹诺酮衍生物具有优异的NAD(P)H氧化酶 抑制活性,完成了本发明。 本发明的化合物具有基于NAD(P)H氧化酶抑制活性的活性氧产生抑制活性,因此可用作糖尿病预防和/或治疗药物,糖耐量异常,高脂血症,脂肪肝 ,糖尿病并发症等。
-
公开(公告)号:US20060229236A1
公开(公告)日:2006-10-12
申请号:US10500113
申请日:2002-12-27
申请人: Shigeki Satoh , Yasuharu Urano , Kazuhiko Osoda , Mitsuru Hosaka , Kozo Sawada , Takayuki Inoue , Hiroaki Mori , Shoji Takagaki , Takao Fujimura , Hideaki Matsuoka , Katsuhiko Yoshizawa
发明人: Shigeki Satoh , Yasuharu Urano , Kazuhiko Osoda , Mitsuru Hosaka , Kozo Sawada , Takayuki Inoue , Hiroaki Mori , Shoji Takagaki , Takao Fujimura , Hideaki Matsuoka , Katsuhiko Yoshizawa
摘要: A cyclic tetrapeptide compound of the formula (I): wherein R1 is hydrogen; R2 is lower alkyl, aryl, optionally substituted ar(lower)alkyl, heterocyclic(lower)alkyl, cyclo(lower)alkyl(lower)alkyl, lower alkylcarbamoyl(lower)alkyl or arylcarbamoyl(lower)alkyl; R3 and R4 are each independently hydrogen, lower alkyl, optionally substituted ar(lower)alkyl, optionally substituted heterocyclic(lower)alkyl or cyclo(lower)alkyl(lower)alkyl, or R3 and R4 are linked together to form lower alkylene or condensed ring, or one of R3 and R4 is linked to the adjacent nitrogen atom to form a ring; R5 is lower alkylene or lower alkenylene, Y is [wherein RY1 is hydrogen, halogen or optionally protected hydroxy, RY2 is hydrogen, halogen, lower alkyl or phenyl, and RY3 is hydrogen or lower alkyl]; R8 is hydrogen or lower alkyl; and n is an integer of 1 or 2, or a salt thereof.
摘要翻译: 式(I)的环状四肽化合物:其中R 1是氢; R 2是低级烷基,芳基,任选取代的芳(低级)烷基,杂环(低级)烷基,环(低级)烷基(低级)烷基,低级烷基氨基甲酰基(低级)烷基或芳基氨基甲酰基 烷基; R 3和R 4各自独立地为氢,低级烷基,任选取代的芳(低级)烷基,任选取代的杂环(低级)烷基或环(低级)烷基(低级) )烷基或R 3和R 4连接在一起形成低级亚烷基或稠环,或者R 3和R 3中的一个 > 4 SUB>与相邻的氮原子连接形成环; R 5是低级亚烷基或低级亚烯基,Y是[其中R Y1是氢,卤素或任选保护的羟基,R Y2是氢, 卤素,低级烷基或苯基,R 3 Y 3是氢或低级烷基]。 R 8是氢或低级烷基; n为1或2的整数,或其盐。
-
公开(公告)号:US20060052599A1
公开(公告)日:2006-03-09
申请号:US11199453
申请日:2005-08-09
申请人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
发明人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
IPC分类号: C07D237/02 , C07C259/04
CPC分类号: C07D213/74 , C07C259/06 , C07D207/14 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
摘要: A compound having the following formula (I): wherein R1 is hydrogen, lower alkyl, lower alkenyl, lower or higher alkynyl, cyclo(lower)alkyl, cyclo(higher)alkyl, cyclo(lower)alkyl(lower)alkyl, cyclo(higher)alkyl(lower)alkyl, cyclo(lower)alkenyl(lower)alkyl, aryl-fused cyclo(lower)alkyl, lower alkoxy, acyl, aryl, ar(lower)alkoxy, ar(lower)alkyl, heteroar(lower) alkyl, amino, heteroaryl, heterocyclyl or heterocyclyl(lower)alkyl, which may be substituted with one or more suitable substituent(s), R2 is hydrogen or lower alkyl, X is arylene, heteroarylene, cycloalkylene, heterocycloalkylene or aryl-fused cycloalkylene, Y is arylene or heteroarylene, which may be substituted with one or more suitable substituent(s), Z is lower alkenylene, which may be substituted with lower alkyl or halogen, or a salt thereof. The compound is useful as a histone deacetylase inhibitor.
摘要翻译: 具有下式(I)的化合物:
-
公开(公告)号:US07465731B2
公开(公告)日:2008-12-16
申请号:US11199453
申请日:2005-08-09
申请人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
发明人: Naoki Ishibashi , Yuki Sawada , Yasuharu Urano , Shigeki Satoh , Yoshikazu Inoue , Yoshiteru Eikyu , Koichiro Mukoyoshi , Kazunori Kamijo , Fumiyuki Shirai , Hisashi Takasugi
IPC分类号: C07D401/12 , C07D403/12 , A61K31/497 , A61K31/506 , A61K31/501
CPC分类号: C07D213/74 , C07C259/06 , C07D207/14 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
摘要: A compound having the formula (I): wherein R1 is hydrogen, lower alkyl, lower alkenyl, lower or higher alkynyl, cyclo(lower)alkyl, cyclo(higher)alkyl, cyclo(lower)alkyl(lower)alkyl, cyclo(higher)alkyl(lower)alkyl, cyclo(lower)alkenyl(lower)alkyl, aryl-fused cyclo(lower)alkyl, lower alkoxy, acyl, aryl, ar(lower)alkoxy, ar(lower)alkyl, heteroar(lower)alkyl, amino, heteroaryl, heterocyclyl or heterocyclyl(lower)alkyl, which may be substituted with one or more suitable substituent(s), R2 is hydrogen or lower alkyl, X is arylene, heterorarylene, cycloalkylene, heterocycloalkylene or aryl-fused cycloalkene, Y is arylene, heteroarylene, which may be substituted with one or more suitable substituent(s), Z lower alenylene, which may be substituted with lower alkyl or halogen, or a salt thereof. The compound is useful as a histone deacetylase inhibitor.
摘要翻译: 具有式(I)的化合物:其中R1是氢,低级烷基,低级烯基,低级或高级炔基,环(低级)烷基,环(高级)烷基,环(低级)烷基(低级)烷基,环 )(低级)烷基,低级(低级)烷基,芳基稠合环(低级)烷基,低级烷氧基,酰基,芳基,芳(低级)烷氧基, ,氨基,杂芳基,杂环基或杂环基(低级)烷基,其可以被一个或多个合适的取代基取代,R 2是氢或低级烷基,X是亚芳基,杂亚芳基,亚环烷基,亚杂环基或芳基稠合的环烯,Y 是亚芳基,可以被一个或多个合适的取代基取代的亚杂芳基,Z可以被低级烷基或卤素取代的低级亚烯基或其盐。 该化合物可用作组蛋白脱乙酰酶抑制剂。
-
公开(公告)号:US07135493B2
公开(公告)日:2006-11-14
申请号:US10754541
申请日:2004-01-12
IPC分类号: A61K31/4188 , A61K31/484 , A61K31/4164 , C07D233/61 , C07D491/113 , C07D487/04 , C07D235/08
CPC分类号: C07D213/75 , C07C57/58 , C07C61/40 , C07C211/50 , C07C211/52 , C07C233/22 , C07C233/31 , C07C233/43 , C07C233/44 , C07C233/51 , C07C271/28 , C07D233/56 , C07D233/64 , C07D233/68 , C07D233/70 , C07D233/90 , C07D235/12 , C07D235/16 , C07D239/47 , C07D317/66 , C07D401/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D471/04 , C07D473/08 , C07D491/04
摘要: A compound having the following formula (I): wherein R1 is N-containing heterocyclic ring optionally substituted with one or more suitable substituent(s), R2 is hydroxyamino, R3 is hydrogen or a suitable substituent, L1 is —(CH2)n— (wherein n is an integer of 0 to 6) optionally substituted with one or more suitable substituent(s), wherein one or more methylene(s) may be replaced with suitable heteroatom(s), and L2 is lower alkenylene, or a salt thereof. The compound is useful as a histone deacetylase inhibitor.
摘要翻译: 具有下式(I)的化合物:其中R 1是任选被一个或多个合适的取代基取代的含N的杂环,R 2是羟基氨基, R 3是氢或合适的取代基,L 1是 - (CH 2 CH 2)n - (其中n 是0至6的整数),其任选地被一个或多个合适的取代基取代,其中一个或多个亚甲基可被适当的杂原子替代,并且L 2低 亚烯基或其盐。 该化合物可用作组蛋白脱乙酰酶抑制剂。
-
公开(公告)号:US08367702B2
公开(公告)日:2013-02-05
申请号:US12680301
申请日:2008-09-25
申请人: Kenichi Onda , Kenichiro Imamura , Fumie Sato , Hiroyuki Moritomo , Yasuharu Urano , Yuki Sawada , Naoki Ishibashi , Keita Nakanishi , Kazuhiro Yokoyama , Shigetada Furukawa , Kazuhiro Momose
发明人: Kenichi Onda , Kenichiro Imamura , Fumie Sato , Hiroyuki Moritomo , Yasuharu Urano , Yuki Sawada , Naoki Ishibashi , Keita Nakanishi , Kazuhiro Yokoyama , Shigetada Furukawa , Kazuhiro Momose
IPC分类号: A61K31/04 , C07D215/38
CPC分类号: C07D401/12 , C07D215/233 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/107
摘要: As a result of extensive studies on NAD(P)H oxidase inhibitors, the present inventors found that a quinolone derivative having, at the 2-position, an alkyl group substituted with a heteroatom or the like has an excellent NAD(P)H oxidase inhibitory activity, and accomplished the present invention. The compound of the present invention has a reactive oxygen species production inhibitory activity based on the NAD(P)H oxidase inhibitory activity, and therefore can be used as an agent for preventing and/or treating diabetes, impaired glucose tolerance, hyperlipidemia, fatty liver, diabetic complications and the like.
摘要翻译: 作为对NAD(P)H氧化酶抑制剂的广泛研究的结果,本发明人发现,在2位具有被杂原子等取代的烷基的喹诺酮衍生物具有优异的NAD(P)H氧化酶 抑制活性,完成了本发明。 本发明的化合物具有基于NAD(P)H氧化酶抑制活性的活性氧产生抑制活性,因此可用作糖尿病预防和/或治疗药物,糖耐量异常,高脂血症,脂肪肝 ,糖尿病并发症等。
-
公开(公告)号:US6008230A
公开(公告)日:1999-12-28
申请号:US51093
申请日:1998-04-14
申请人: Teruo Oku , Yoshio Kawai , Shigeki Satoh , Hitoshi Yamazaki , Natsuko Kayakiri , Yasuharu Urano , Kousei Yoshihara , Noriko Yoshida
发明人: Teruo Oku , Yoshio Kawai , Shigeki Satoh , Hitoshi Yamazaki , Natsuko Kayakiri , Yasuharu Urano , Kousei Yoshihara , Noriko Yoshida
IPC分类号: A61K31/00 , A61K31/435 , A61K31/4353 , A61K31/4365 , A61K31/47 , A61K31/4706 , A61K31/472 , A61K31/4725 , A61K31/4738 , A61K31/4745 , A61K31/495 , A61K31/496 , A61K31/505 , A61K31/513 , A61K31/517 , A61K31/529 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/542 , A61P19/00 , A61P19/08 , C07D215/20 , C07D215/40 , C07D215/42 , C07D215/44 , C07D215/46 , C07D215/48 , C07D215/54 , C07D215/56 , C07D215/60 , C07D221/12 , C07D237/28 , C07D239/74 , C07D239/88 , C07D239/94 , C07D241/42 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D495/04 , C07D513/04 , C07D513/14 , C07D521/00 , C07F7/08 , C07F7/10 , C07F7/18
CPC分类号: C07D231/12 , C07D215/40 , C07D215/42 , C07D215/44 , C07D215/46 , C07D215/48 , C07D215/54 , C07D215/56 , C07D215/60 , C07D221/12 , C07D233/56 , C07D237/28 , C07D239/74 , C07D239/88 , C07D241/42 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D495/04 , C07D513/14 , C07F7/0812 , C07F7/1856
摘要: This invention relates to a quinoline compound of the formula: ##STR1## wherein R.sup.1 is a pyridyl group or aryl, each of which may be substituted with suitable substituent(s),A is --COHN-- or --NHCO--,n is an integer of 0 or 1, and ##STR2## is a group of the formula: ##STR3## In which R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined,and pharmaceutically acceptable salt thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prevention and/or the treatment of bone diseases caused by abnormal bone metabolism in human being or animals.
摘要翻译: PCT No.PCT / JP96 / 02981 Sec。 371日期:1998年4月14日 102(e)1998年4月14日PCT PCT 1996年10月15日PCT公布。 公开号WO97 / 14681 日本特开2006年4月24日本发明涉及下式的喹啉化合物:其中R 1为吡啶基或芳基,其各自可被适当的取代基取代,A为-COHN-或-NHCO-,n为 0或1的整数,并且是下式的基团:其中R 2,R 3,R 4,R 5,R 6和R 7如上所定义,及其药学上可接受的盐,其制备方法, 以及用于预防和/或治疗由人或动物的异常骨代谢引起的骨疾病的方法。
-
-
-
-
-
-
-
-